Tax on pharmaceuticals would be outside scope of Britain’s trade agreement with the US
Tax on pharmaceuticals would be outside scope of Britain’s trade agreement with the US
Copy link
Ministers called on to protect drug supplies and NHS costs from transatlantic trade shock
President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.
New tax will hit branded drugs and active ingredients while exempting generics for at least one year
The US president has told GSK and AstraZeneca to ‘negotiate harder with foreign freeloading nations’
British drug companies could see all their US profits wiped out
US president has said that he will use tariffs to bring down costly medical drugs, but the impact remains uncertain.
Trump says pharma tariffs could eventually reach up to 250%
